Non-Viral TCR Gene Therapy

首次发布于 2019 年 9 月 25 日

A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease

计划入组 31 人 · 首次发布于 2025 年 6 月 10 日

Study of Viral Transduction of Human Auditory Sensory Cells for the Development of Gene Therapy

计划入组 100 人 · 首次发布于 2019 年 6 月 25 日

FVIII gene therapy (Poseida Therapeutics/Takeda)

Non-viral gene therapy (Myosana Therapeutics)

Synthetic AAV (Non-viral) ELOVL2 Gene Therapy(Visgenx)

CELL AND GENE THERAPY CATAPULT

United Kingdom

Frantz Viral Therapeutics, LLC

United States

VIETNAM VIRAL HEPATITIS ALLIANCE

United States

DNA Nanobots Raises $3.5M to Advance Non-Viral Gene Therapy Platform Using DNA Origami Technology

Helex Secures $3.5M Seed Funding to Develop Non-Viral Gene Therapy for Polycystic Kidney Disease

Cellectis Advances Non-Viral Gene Therapy with Circular DNA Templates and TALE Base Editor Safety Data